A review detailed how cytochrome P450 enzymes metabolize anandamide into structurally diverse lipids, some of which activate cannabinoid receptors, complicating the development of FAAH inhibitor drugs.
Read this if you are interested in the biochemistry of how the body processes endocannabinoids and implications for drug development.
A P450-derived anandamide metabolite is a potent CB2 receptor agonist
What the researchers found
The review focused on an underappreciated aspect of endocannabinoid biology: the oxidation of anandamide by cytochrome P450 enzymes.
While FAAH is the primary enzyme that breaks down anandamide, several P450 enzymes (CYP3A4, CYP4F2, CYP4X1, and the highly variable CYP2D6) also metabolize anandamide into structurally diverse lipid products.
Critically, one P450-derived epoxide of anandamide was found to be a potent agonist at CB2 receptors. This meant that blocking FAAH alone (the approach being developed for pain treatment) might not fully control endocannabinoid signaling because alternative metabolic pathways would still produce active compounds.
The genetic variability in CYP2D6 across individuals could lead to different responses to endocannabinoid-targeting drugs.
Why it matters
Understanding that multiple enzyme systems process anandamide into bioactive products was essential for developing effective endocannabinoid-targeting drugs, particularly FAAH inhibitors being developed for pain and inflammation.
The numbers in context
Four P450 enzymes identified: CYP3A4, CYP4F2, CYP4X1, CYP2D6. One P450-derived epoxide was a potent CB2 agonist. CYP2D6 is highly polymorphic across populations.
How the study worked
Comprehensive review published in Pharmacological Reviews examining the cytochrome P450-mediated oxidation pathways of anandamide, their physiological significance, and implications for drug development.
What this study cannot tell us
Much of the evidence came from in vitro enzyme studies. The physiological relevance of P450-mediated anandamide metabolism in vivo required further investigation. The clinical implications were still theoretical.
How to read the evidence
Comprehensive review in a leading pharmacology journal synthesizing biochemical evidence across multiple enzyme pathways.
When this study was published
Published in 2010. FAAH inhibitor development has continued with these complexities in mind.
The bigger picture
This research highlighted the complexity of the endocannabinoid system beyond simple production and degradation, with multiple metabolic pathways generating diverse bioactive lipids that could influence therapeutic outcomes.
Questions still open
- How do P450-mediated anandamide metabolites contribute to endocannabinoid signaling in vivo? Should FAAH inhibitor drug development account for these alternative metabolic pathways?
Common questions
What does this have to do with cannabis?
Why does genetic variation in CYP2D6 matter?
Read the original research
Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.
Pharmacological reviews, 62(1), 136-54
Citation
Snider, Natasha T; Walker, Vyvyca J; Hollenberg, Paul F. (2010). Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.. Pharmacological reviews, 62(1), 136-54. https://doi.org/10.1124/pr.109.001081
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)
- THC and Antibiotics: Is It Safe to Use Cannabis While on Antibiotics
- THC and Caffeine: The Most Common Drug Combo on Earth
- THC and Diabetes Medication: Blood Sugar Interactions